PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-6.78%
Revenue decline while 3088.T shows 2.40% growth. Joel Greenblatt would examine competitive position erosion.
-7.09%
Cost reduction while 3088.T shows 1.38% growth. Joel Greenblatt would examine competitive advantage.
-5.59%
Gross profit decline while 3088.T shows 4.34% growth. Joel Greenblatt would examine competitive position.
1.27%
Margin expansion 50-75% of 3088.T's 1.90%. Martin Whitman would scrutinize competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-0.55%
Operating expenses reduction while 3088.T shows 3.61% growth. Joel Greenblatt would examine advantage.
-5.97%
Total costs reduction while 3088.T shows 1.35% growth. Joel Greenblatt would examine advantage.
-100.00%
Both companies reducing interest expense. Martin Whitman would check industry trends.
2.06%
Similar D&A growth to 3088.T's 1.90%. Walter Schloss would investigate industry patterns.
-18.12%
EBITDA decline while 3088.T shows 8.28% growth. Joel Greenblatt would examine position.
-12.16%
EBITDA margin decline while 3088.T shows 5.75% growth. Joel Greenblatt would examine position.
-24.32%
Operating income decline while 3088.T shows 16.98% growth. Joel Greenblatt would examine position.
-18.82%
Operating margin decline while 3088.T shows 14.24% growth. Joel Greenblatt would examine position.
26.39%
Other expenses growth while 3088.T reduces costs. John Neff would investigate differences.
-22.29%
Pre-tax income decline while 3088.T shows 13.62% growth. Joel Greenblatt would examine position.
-16.64%
Pre-tax margin decline while 3088.T shows 10.95% growth. Joel Greenblatt would examine position.
-21.16%
Tax expense reduction while 3088.T shows 13.64% growth. Joel Greenblatt would examine advantage.
-22.82%
Net income decline while 3088.T shows 13.81% growth. Joel Greenblatt would examine position.
-17.21%
Net margin decline while 3088.T shows 11.14% growth. Joel Greenblatt would examine position.
-22.81%
EPS decline while 3088.T shows 15.75% growth. Joel Greenblatt would examine position.
-22.81%
Diluted EPS decline while 3088.T shows 15.79% growth. Joel Greenblatt would examine position.
-0.00%
Both companies reducing share counts. Martin Whitman would check patterns.
-0.00%
Both companies reducing diluted shares. Martin Whitman would check patterns.